Eun-Kyoung Hahm

Title: Eun-Kyoung Hahm: Innovator in ADHD Research

Introduction

Eun-Kyoung Hahm is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of neuroscience, particularly in the study of attention deficit hyperactivity disorder (ADHD). His innovative research has led to the development of a novel mouse model that aids in the screening of drugs for ADHD.

Latest Patents

Eun-Kyoung Hahm holds a patent titled "Screening of drug for attention deficit hyperactive disorder by using GIT1 knock-out mice as a novel ADHD mouse model." This patent describes a method of utilizing mammals, excluding humans, as models for ADHD. The method involves knocking out genes of G protein-coupled receptor kinase interacting protein 1 (GIT1), which is a neuronal synapse protein in the brain. The patent also details the analysis of GIT1 knock-out mice in various biological aspects, including molecular biology, cellular biology, electrical biology, and animal behavior. The screening method allows for the observation of excessive behavior associated with ADHD and the recovery of theta waves in the frontal lobe through the administration of candidate drug materials.

Career Highlights

Eun-Kyoung Hahm is affiliated with the Korea Advanced Institute of Science and Technology, where he conducts his research. His work has garnered attention for its potential to improve the understanding and treatment of ADHD. With a focus on innovative methodologies, he continues to contribute to advancements in the field.

Collaborations

Eun-Kyoung Hahm collaborates with notable colleagues, including Eunjin Kim and Won Mah. Their combined expertise enhances the research efforts in ADHD and related fields.

Conclusion

Eun-Kyoung Hahm's innovative work in ADHD research exemplifies the importance of scientific inquiry in developing effective treatments. His contributions through patenting novel methodologies highlight the potential for advancements in understanding and addressing ADHD.